Glaxo and Sanofi Plan$620 Million U.K. Vaccine Deal, human testing in September

GlaxoSmithKline Plc and Sanofi, partners developing a potential coronavirus vaccine, are discussing a 500 million pound ($620 million) deal to supply the U.K. government with the shot, assuming it’s successful, said a…

Read More